STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

Enrollment of Black and Hispanic students in medical schools dropped precipitously last year after the Supreme Court banned ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

A German research team’s discoveries about autoimmune diseases are opening up new possibilities for patients with lupus and ...

The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...

The White House gives agencies more leeway with one of the few tools against meth use: financial incentives, or "contingency ...

Health insurers like UnitedHealth are under tremendous public scrutiny for tactics such as prior authorization and care ...